Capital Anstalt Alpha serves as Executive at RADIENT PHARMACEUTICALS Corp, where they oversee executive responsibilities. Since joining the company, Capital Anstalt Alpha has executed 16 insider transactions totaling $2.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 4, 2018 involved selling 10,000 shares valued at $20.8K.
Capital Anstalt Alpha currently holds 735,771 shares of RADIENT PHARMACEUTICALS Corp (RXPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Anstalt Alpha has been a net seller of RXPC stock. They have purchased $295.2K and sold $2.2M worth of shares.
Capital Anstalt Alpha's most recent insider trade was on May 4, 2018, when they sold 10,000 shares at $2.08 per share.
Get notified when new Form 4 filings are submitted
| $2.30 |
| Discretionary |
| Feb 21, 2018 | WPCS | $360.6K | Sale | 138,702 | $2.60 | Discretionary |
| Feb 20, 2018 | WPCS | $1.3M | Sale | 356,151 | $3.53 | Discretionary |
| Feb 16, 2018 | WPCS | $371.7K | Sale | 135,651 | $2.74 | Discretionary |
| Nov 28, 2016 | MBOT | $0 | Other | 9,753,549 | $N/A | Discretionary |
| Nov 28, 2016 | MBOT | $0 | Other | 7,977,092 | $N/A | Discretionary |
| Mar 4, 2014 | BLGA | $1.5K | Sale | 50,000 | $0.03 | Discretionary |
| Feb 26, 2014 | BLGA | $1.6K | Sale | 39,000 | $0.04 | Discretionary |
| Nov 10, 2011 | BLGA | $0 | Purchase | 4,000,000 | $N/A | Discretionary |
| Oct 28, 2011 | RXPC | $0 | Sale | 5,052,094 | $N/A | Discretionary |
| Oct 27, 2011 | RXPC | $0 | Sale | 1,400,000 | $N/A | Discretionary |
| Jul 11, 2011 | RXPC | $146.1K | Sale | 1,460,688 | $0.10 | Discretionary |
| Jun 3, 2011 | BLGA | $143.5K | Purchase | 4,782,915 | $0.03 | Discretionary |
| Jun 1, 2011 | BLGA | $86.7K | Purchase | 2,889,617 | $0.03 | Discretionary |
| Sep 16, 2008 | BLGA | $65.0K | Purchase | 650,296 | $0.10 | Discretionary |